These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 36546737)
21. Single-minded homolog 2 as a potential prognostic signature and assessment of its correlation with immune cell infiltration in pancreatic cancer. Hu Q; Wen N; Li F; Yang D; Yue C; Wu Z; Li M; Lu H Pol J Pathol; 2023; 74(4):232-247. PubMed ID: 38477085 [TBL] [Abstract][Full Text] [Related]
22. The construction and analysis of a ferroptosis-related gene prognostic signature for pancreatic cancer. Jiang P; Yang F; Zou C; Bao T; Wu M; Yang D; Bu S Aging (Albany NY); 2021 Apr; 13(7):10396-10414. PubMed ID: 33819918 [TBL] [Abstract][Full Text] [Related]
23. A Four Autophagy-Related Gene-Based Prognostic Signature for Pancreatic Cancer. Zhou Q; Chen X; Chen Q; Liu H; Hao L Crit Rev Eukaryot Gene Expr; 2021; 31(4):89-100. PubMed ID: 34587439 [TBL] [Abstract][Full Text] [Related]
24. Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer. Meng F; Hua S; Chen X; Meng N; Lan T BMC Med Genomics; 2023 Oct; 16(1):263. PubMed ID: 37880742 [TBL] [Abstract][Full Text] [Related]
25. Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis. Wang Y; Kong Y; Yang Q; Zhong C; Zhou D Eur J Med Res; 2024 Apr; 29(1):221. PubMed ID: 38581008 [TBL] [Abstract][Full Text] [Related]
26. The Senescence-Related Signature Predicts Prognosis and Characterization of Tumor Microenvironment Infiltration in Pancreatic Cancer. Hua H; Zheng C; Fan J; Li X; Xie W; Chen J; Yu C Biomed Res Int; 2022; 2022():1916787. PubMed ID: 36518628 [TBL] [Abstract][Full Text] [Related]
27. Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584 [TBL] [Abstract][Full Text] [Related]
28. High expression of IL4I1 is correlated with poor prognosis and immune infiltration in thyroid cancer. Zhu L; Wang J; Hu J BMC Endocr Disord; 2023 Jul; 23(1):148. PubMed ID: 37434155 [TBL] [Abstract][Full Text] [Related]
29. CHST11 gene expression and DNA methylation in breast cancer. Herman D; Leakey TI; Behrens A; Yao-Borengasser A; Cooney CA; Jousheghany F; Phanavanh B; Siegel ER; Safar AM; Korourian S; Kieber-Emmons T; Monzavi-Karbassi B Int J Oncol; 2015 Mar; 46(3):1243-51. PubMed ID: 25586191 [TBL] [Abstract][Full Text] [Related]
30. Immunocyte Infiltration Analysis and Immunohistochemistry Identify EVL as a Potential Prognostic Biomarker for Pancreatic Cancer. Du Y; Zhu L; Li X; Shi H; Jiang W; Zhou W J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983615 [TBL] [Abstract][Full Text] [Related]
31. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
32. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
33. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma. Hu Y; Chen Y Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315 [TBL] [Abstract][Full Text] [Related]
34. Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer. Xie Q; Ou-Yang W; Zhang M; Wang H; Yue Q J Cancer; 2020; 11(10):2852-2863. PubMed ID: 32226503 [No Abstract] [Full Text] [Related]
35. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. Yan C; Niu Y; Li F; Zhao W; Ma L J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146 [TBL] [Abstract][Full Text] [Related]
36. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer. Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L Front Immunol; 2022; 13():943389. PubMed ID: 36003381 [TBL] [Abstract][Full Text] [Related]
37. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633 [TBL] [Abstract][Full Text] [Related]
38. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis. Cui Y; Zhou Z; Chai Y; Zhang Y J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313 [TBL] [Abstract][Full Text] [Related]
39. Identify novel inflammation-related prognostic signature in pancreatic cancer patients. Sun Y; Zhang X; Zhu H Medicine (Baltimore); 2024 Feb; 103(7):e36932. PubMed ID: 38363947 [TBL] [Abstract][Full Text] [Related]
40. A TP53-associated immune prognostic signature for the prediction of the overall survival and therapeutic responses in pancreatic cancer. Liu Y; Cheng L; Song X; Li C; Zhang J; Wang L Math Biosci Eng; 2022 Jan; 19(1):191-208. PubMed ID: 34902987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]